Exomorphic Biotech™ innovatively merges the capabilities of exosomes and liposomes to create supercharged exosomes, known as Hybrosome™. By fusing exosomes with liposomes, essential amino acids for protein synthesis are delivered directly to the cells, making this hybrid technology a significant advancement in regenerative medicine.